MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Osha Workplace Safety
20 questions · exam conditions
0:00
Osha Workplace SafetyQuestion 1 of 20

A pharmacy that compounds non-sterile hazardous drugs (e.g., crushing and encapsulating oral antineoplastic tablets) must perform this work in what type of environment under USP 800?

A standard pharmacy clean room with ISO 7 air classification
A containment ventilated enclosure (CVE) or isolator providing negative pressure and HEPA filtration
An open counter area with chemotherapy gloves only
A Class I Biological Safety Cabinet
← Back to quizzes

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Osha Workplace Safety

Practice Osha Workplace Safety in MPJE: Multistate Pharmacy Jurisprudence Examination with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Osha Workplace Safety, giving you a quick way to practice the rules, question types, and explanations that matter most for MPJE: Multistate Pharmacy Jurisprudence Examination.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A pharmacy that compounds non-sterile hazardous drugs (e.g., crushing and encapsulating oral antineoplastic tablets) must perform this work in what type of environment under USP 800?

  1. A standard pharmacy clean room with ISO 7 air classification
  2. A containment ventilated enclosure (CVE) or isolator providing negative pressure and HEPA filtration (correct answer)
  3. An open counter area with chemotherapy gloves only
  4. A Class I Biological Safety Cabinet
Explanation: USP 800 requires non-sterile hazardous drug compounding to be performed in a containment ventilated enclosure (CVE) - a device that uses negative pressure and HEPA filtration to capture drug particles and protect the worker and environment. A standard ISO 7 clean room does not provide containment for non-sterile hazardous drug work. An open counter is inadequate. Class I BSCs provide some protection but are not the standard designation under USP 800 for non-sterile HD compounding; CVEs are the primary requirement.

Question 2

Which organization publishes the list of hazardous drugs that forms the basis for USP 800 compliance determinations in pharmacy?

  1. The Food and Drug Administration (FDA)
  2. The Drug Enforcement Administration (DEA)
  3. The National Institute for Occupational Safety and Health (NIOSH) (correct answer)
  4. The United States Pharmacopeial Convention (USP)
Explanation: NIOSH publishes the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, which is the authoritative reference used to identify hazardous drugs for purposes of USP 800 and OSHA compliance. USP 800 incorporates the NIOSH list as its basis for defining which drugs require hazardous drug handling precautions. The FDA, DEA, and USP itself do not publish this specific hazardous drug classification list.

Question 3

A pharmacy employee who regularly handles hazardous drugs requests a copy of her medical surveillance records related to occupational exposure. Under OSHA regulations, what is the employer's obligation?

  1. The employer must provide the employee access to her medical surveillance and exposure records upon request, at no cost (correct answer)
  2. Medical records are confidential and may not be shared with the employee without a court order
  3. The employer may charge a reasonable fee before releasing the records
  4. Records only need to be made available if the employee files a formal complaint with OSHA
Explanation: OSHA's Access to Employee Exposure and Medical Records Standard (29 CFR 1910.1020) grants employees the right to access their occupational exposure records and medical records maintained by the employer, upon request and at no cost. This right is fundamental to worker protection and informed consent regarding occupational health risks. No court order, fee, or formal complaint is required to trigger this right.

Question 4

OSHA requires pharmacies to have a written Exposure Control Plan when employees have occupational exposure to bloodborne pathogens. Which employee group at a retail pharmacy MOST likely requires coverage under this plan?

  1. Pharmacists and technicians who administer injections or handle sharps used for patient care (correct answer)
  2. All pharmacy employees regardless of their actual job duties
  3. Only pharmacists who have direct patient contact in clinical settings
  4. Only employees who have previously tested positive for a bloodborne pathogen
Explanation: OSHA's Bloodborne Pathogens Standard applies to employees who have reasonably anticipated occupational exposure to blood or other potentially infectious materials - including those who administer injections, handle sharps, or may contact blood during immunization services. Not all retail pharmacy employees meet this threshold. The plan is not universally required for all employees regardless of exposure risk, and prior pathogen status is irrelevant to the coverage determination.

Question 5

A pharmacy employee believes the pharmacy is violating OSHA hazardous drug standards and faces retaliation for raising concerns. Under OSHA's whistleblower protection provisions, what protection does the employee have?

  1. No protection; employees may be disciplined for reporting safety complaints outside normal channels
  2. Protection only if the employee holds a current state pharmacy license
  3. Protection only if the employee first reports concerns to the DEA
  4. Employees are protected from retaliation for reporting safety concerns under OSHA whistleblower provisions. (correct answer)
Explanation: OSHA Section 11(c) of the Occupational Safety and Health Act prohibits employers from retaliating against employees who report safety and health concerns, file OSHA complaints, or otherwise exercise their rights under the Act. This protection applies to all employees regardless of licensure status. Employees do not need to report to the DEA first; OSHA complaints are filed directly with OSHA.

Question 6

A retail pharmacy begins offering immunization services. The pharmacist-in-charge wants to ensure OSHA compliance. Which action is MOST important to address OSHA's Bloodborne Pathogens Standard requirements?

  1. Register the immunization service with the state board as a clinical pharmacy practice site
  2. Obtain a separate DEA registration for immunization-related controlled substances
  3. Notify the FDA that the pharmacy is now a vaccination administration site
  4. Create a written Exposure Control Plan and provide hepatitis B vaccination to eligible employees. (correct answer)
Explanation: When a pharmacy begins administering injections, employees have occupational exposure to bloodborne pathogens (via needlestick risk). OSHA's Bloodborne Pathogens Standard requires: a written Exposure Control Plan identifying at-risk employees; hepatitis B vaccination offered at no cost; employee training on bloodborne hazards and precautions; and sharps disposal containers. State board registration, DEA registration, and FDA notification are not triggered by adding immunization services.

Question 7

A pharmacy employee regularly handles methotrexate tablets for a mail-order operation. The NIOSH list classifies methotrexate as a hazardous drug. What minimum PPE is required under USP 800 for this activity?

  1. At minimum, ASTM D6978-compliant chemotherapy gloves; additional PPE based on risk assessment of the specific activity (correct answer)
  2. No PPE is required because methotrexate is an oral solid dosage form
  3. Full respiratory protection including a powered air-purifying respirator (PAPR) for all tablet handling
  4. A DEA Form 222 must be completed before handling any NIOSH-listed hazardous drug
Explanation: USP 800 requires at minimum one pair of ASTM D6978-tested chemotherapy gloves when handling hazardous drugs in any dosage form, including solid oral dosage forms. Additional PPE (gown, eye/face protection, respiratory protection) is required when handling damaged or broken tablets, performing manipulation, or when splashing/aerosolization risk is present. A PAPR is not universally required for routine tablet handling. Methotrexate's oral form does not exempt it from PPE requirements. DEA Form 222 is for Schedule I/II ordering.

Question 8

A pharmacy technician who is pregnant asks to be reassigned away from hazardous drug compounding duties. Under USP 800 and OSHA reproductive hazard guidelines, which response BEST reflects the employer's obligation?

  1. The employer may deny the request because all employees must be able to perform all job duties
  2. The employer must immediately terminate the employee to eliminate liability
  3. The employer must offer an alternative assignment if available and inform the employee of reproductive risks. (correct answer)
  4. The employer must require the employee to obtain a physician's note before reassignment can be considered
Explanation: USP 800 and OSHA guidelines recognize reproductive toxicity as a key hazard of antineoplastic and other hazardous drugs. Employees with reproductive risk -- including pregnant workers, those planning to conceive, and those who are breastfeeding -- must be informed of the risks in writing. The employee then decides whether to continue working with hazardous drugs. USP 800 guidance supports offering alternative assignments to employees who decline HD duties, and applicable federal and state employment and accommodation laws may require this; however, the precise scope of any mandatory reassignment obligation depends on jurisdiction and circumstances. C correctly reflects the core obligations. A is incorrect because denying all accommodation conflicts with both USP 800 guidance and applicable employment laws. B is incorrect because terminating an employee who requests accommodation from reproductive hazards is unlawful discrimination. D is incorrect because a physician's note is not a prerequisite for initiating the accommodation or risk communication process.

Question 9

A pharmacy employee is exposed to a hazardous drug spill and later develops an occupational illness. Under OSHA's recordkeeping requirements, what must the employer do?

  1. Report the illness to the FDA within 15 days using MedWatch
  2. Record the work-related illness on the OSHA 300 Log and maintain it for 5 years (correct answer)
  3. Submit an adverse event report to the DEA within 72 hours
  4. Notify the state board of pharmacy within 10 days of the employee's diagnosis
Explanation: OSHA requires employers to record work-related injuries and illnesses on the OSHA Form 300 (Log of Work-Related Injuries and Illnesses) and retain these records for 5 years. An occupational illness caused by hazardous drug exposure is a recordable event. Reporting to the FDA, DEA, or state board is not required for occupational illness events - those agencies regulate drugs and pharmacy practice, not employee health recordkeeping.

Question 10

Under OSHA's Hazard Communication Standard (HazCom), what must pharmacy employers provide to employees who work with hazardous chemicals?

  1. A DEA Form 41 for each hazardous chemical on site
  2. A signed waiver from each employee acknowledging exposure risk
  3. Access to Safety Data Sheets (SDS), hazard training, and properly labeled containers (correct answer)
  4. A written request to the FDA listing all hazardous chemicals used in the pharmacy
Explanation: OSHA's Hazard Communication Standard (29 CFR 1910.1200) requires employers to provide employees with: (1) Safety Data Sheets for all hazardous chemicals in the workplace; (2) employee training on chemical hazards and protective measures; and (3) properly labeled containers identifying chemical hazards. The DEA, signed waivers, and FDA notifications are not components of HazCom compliance.

Question 11

A pharmacy receives a large spill of a liquid hazardous drug in the compounding area. What is the correct initial response according to OSHA and USP 800 guidelines?

  1. Use paper towels to absorb the spill immediately and dispose of them in the regular trash
  2. Wear PPE, use a spill kit to contain and clean the spill, dispose of materials as hazardous waste. (correct answer)
  3. Evacuate the entire pharmacy and call the DEA to report the spill within 1 hour
  4. Notify the FDA's drug safety reporting line before beginning cleanup
Explanation: USP 800 and OSHA guidelines require use of a dedicated hazardous drug spill kit and appropriate PPE (chemotherapy-rated gloves, gown, eye protection, and respiratory protection if aerosols may be generated) for hazardous drug spill cleanup. All cleanup materials are hazardous waste and must be disposed of accordingly. Using regular trash is a regulatory violation. The DEA and FDA are not notified of hazardous drug spills; OSHA notification may be required only if an employee is injured.

Question 12

An OSHA compliance officer inspects a pharmacy and finds that employees handling hazardous drugs have not received required hazard communication training. What enforcement action may OSHA take?

  1. OSHA may only issue a written warning for a first-time violation
  2. OSHA may suspend the pharmacy's DEA registration pending training completion
  3. OSHA may issue citations and financial penalties; repeated or willful violations carry higher penalties (correct answer)
  4. OSHA may only refer the matter to the state board of pharmacy for action
Explanation: OSHA has authority to issue citations and assess financial penalties for workplace safety violations. Penalty amounts depend on the violation classification (other-than-serious, serious, willful, or repeated). OSHA does not have authority to suspend DEA registrations or delegate enforcement to state boards; those are separate regulatory bodies. First-time violations may result in monetary penalties, not merely written warnings.

Question 13

USP 800 requires that the negative-pressure buffer room used for sterile hazardous drug compounding undergo environmental wipe sampling. What is the PRIMARY purpose of this requirement?

  1. To verify that the buffer room meets ISO 7 air classification standards
  2. To confirm that controlled substances are not being diverted from the compounding area
  3. To detect hazardous drug surface contamination and ensure containment controls are effective (correct answer)
  4. To satisfy OSHA's bloodborne pathogen surface testing requirement
Explanation: Wipe sampling under USP 800 is used to detect surface contamination by hazardous drugs in compounding areas and to evaluate the effectiveness of engineering controls, cleaning procedures, and work practices. Positive findings trigger investigation and remediation. ISO air classification is monitored by particle counting, not wipe sampling. Wipe sampling is not a diversion detection tool and is not an OSHA bloodborne pathogen requirement.

Question 14

A pharmacy chain's management team is evaluating whether to implement a closed-system drug transfer device (CSTD) for hazardous drug preparation. Which argument BEST supports adopting CSTDs?

  1. CSTDs mechanically prevent escape of drug or vapor during transfer, reducing employee hazardous drug exposure beyond what BSC/CACI containment alone provides (correct answer)
  2. CSTDs eliminate the need for chemotherapy gloves and gowns during all hazardous drug preparation
  3. CSTDs are required by DEA regulations for Schedule II chemotherapy agents
  4. CSTDs satisfy USP 797 ISO 5 air classification requirements for sterile compounding
Explanation: Closed-system drug transfer devices (CSTDs) provide an additional layer of protection by mechanically containing hazardous drug aerosols and liquids during preparation and administration. USP 800 recommends CSTDs as a supplemental engineering control during sterile HD compounding, beyond the primary protection of BSCs and CACIs. CSTDs do not eliminate PPE requirements; they supplement, not replace, other controls. CSTDs are not required by the DEA and do not establish ISO air classification.

Question 15

A pharmacy is disposing of unused hazardous drug waste from compounding activities. Under OSHA and EPA regulations, how must this waste be handled?

  1. Hazardous drug waste must be placed in labeled containers and disposed of per EPA and state hazardous waste regulations. (correct answer)
  2. Hazardous drug waste must be returned to the original manufacturer using DEA Form 41
  3. Hazardous drug waste may be placed in a red sharps container and autoclaved on site
  4. Hazardous drug waste may be flushed down the drain when sufficiently diluted with water, as dilution renders it non-hazardous.
Explanation: Hazardous drug waste is subject to EPA RCRA regulations as hazardous chemical waste. It must be segregated from other waste, collected in clearly labeled hazardous waste containers, and disposed of in compliance with applicable RCRA and state hazardous waste regulations. Depending on the waste classification (P-listed, U-listed, characteristic, or state-regulated) and applicable state implementation, disposal through a licensed hazardous waste contractor is typically required. A correctly identifies this framework while acknowledging state-level variation. B is incorrect because DEA Form 41 applies to the destruction of controlled substances, not hazardous chemical waste disposal. C is incorrect because hazardous drug waste may not be placed in sharps containers and autoclaved; autoclaving addresses biological hazards, not chemical hazards. D is incorrect because drain disposal of hazardous drug waste is prohibited regardless of dilution; dilution does not render hazardous drug waste non-hazardous or eliminate disposal obligations.

Question 16

An employer provides free hepatitis B vaccinations to pharmacy employees who administer injections. An employee declines the vaccine. What must the employer do?

  1. Require the employee to accept the vaccine as a condition of continued immunization duties
  2. Terminate the employee for refusing required occupational health measures
  3. Obtain a signed declination statement and keep the vaccine available for future acceptance. (correct answer)
  4. Report the declination to OSHA within 30 days
Explanation: OSHA's Bloodborne Pathogens Standard allows employees to decline hepatitis B vaccination. If an employee declines, the employer must obtain a signed declination statement, which is retained in the employee's records. The vaccine must remain available to the employee at no cost if they later choose to receive it. Employees cannot be required to accept vaccination or terminated for declination. OSHA does not require notification for individual employee declinations.

Question 17

A pharmacy is evaluating whether a newly approved oral medication should be classified as a hazardous drug requiring USP 800 controls. Which approach BEST reflects the appropriate assessment process?

  1. Only drugs classified as Schedule II by the DEA require hazardous drug assessment
  2. All new oral medications automatically require hazardous drug handling until the FDA approves a safety waiver
  3. Hazardous drug classification applies only to intravenous medications
  4. Compare the drug's pharmacological profile to the NIOSH criteria (carcinogenicity, teratogenicity, reproductive toxicity, organ toxicity, genotoxicity, or NIOSH list appearance) to determine classification (correct answer)
Explanation: USP 800 requires each facility to evaluate drugs against NIOSH hazard criteria: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, and structural/toxicity profile similarity to existing hazardous agents. If the drug appears on the current NIOSH list or meets these criteria, hazardous drug handling controls apply. DEA scheduling is unrelated to hazardous drug classification. The FDA does not issue safety waivers for this purpose, and route of administration (oral vs. IV) alone does not determine hazardous classification.

Question 18

A retail pharmacy dispenses oral hazardous drugs (e.g., oral antineoplastics). Under USP 800, what minimum personal protective equipment (PPE) must employees wear when handling these medications?

  1. Full respiratory protection (N-95 mask) and a Class III BSC are required for all oral hazardous drug dispensing
  2. No PPE is required for commercially manufactured oral hazardous drugs in final dosage form
  3. Eye protection and a full-face shield are the only required PPE elements
  4. Chemotherapy gloves meeting ASTM D6978 standards; additional PPE (gown, eye protection) based on the activity and risk assessment (correct answer)
Explanation: USP 800 requires that employees handling oral hazardous drugs in final dosage form (counting tablets, pouring liquids) wear at minimum one pair of chemotherapy-tested gloves meeting ASTM D6978. Additional PPE such as a gown and eye protection may be required based on the specific activity and institutional risk assessment. Full respiratory protection and Class III BSCs are not universally required for routine oral hazardous drug dispensing. Asserting no PPE is needed conflicts with USP 800 requirements.

Question 19

Which federal agency enforces workplace safety standards applicable to pharmacy employees, including those related to hazardous drug exposure?

  1. The Occupational Safety and Health Administration (OSHA) (correct answer)
  2. The Drug Enforcement Administration (DEA)
  3. The Food and Drug Administration (FDA)
  4. The National Institute for Occupational Safety and Health (NIOSH)
Explanation: OSHA, under the Department of Labor, is the federal agency responsible for setting and enforcing workplace safety and health standards, including those protecting pharmacy employees from hazardous drug exposure. NIOSH conducts research and issues guidance (including the hazardous drug list) but does not have enforcement authority. The DEA and FDA regulate controlled substances and drug products, respectively - not workplace safety.

Question 20

A new pharmacy employee is hired to work in the sterile compounding area where hazardous drugs are prepared. Under OSHA and USP 800, when must initial hazardous drug training be completed?

  1. Within 30 days of the employee's first hazardous drug exposure
  2. Before the employee begins working with hazardous drugs (correct answer)
  3. Within 1 year of hire, consistent with continuing education cycles
  4. Only after the employee requests training in writing
Explanation: OSHA's Hazard Communication Standard and USP 800 both require that employees receive training on hazardous drug risks before they begin working with or around such drugs. Initial training must occur prior to the first exposure, not after a delay period. Annual retraining is also required. Training cannot be deferred to a CE cycle or contingent on an employee request.